Evidence map›Paper›PMID 42496063›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Aberrant GRP78 Phase Transition Sustains Endothelial IRE1α Signaling and Drives Blood-Brain Barrier Failure in Cerebral Amyloid Angiopathy.

Honglin Zheng, Qiang Li, Haiyang Luo, Yapei Yuan, Na Zhang, Yongting Lu, Suying Duan, Jieshi Zhong, Hang Zhang, Chenyang Liu and 10 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Honglin ZhengDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0009-0008-1002-6761
Qiang LiDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0009-0003-3159-0234
Haiyang LuoDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yapei YuanDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Na ZhangDepartment of Pathology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yongting LuDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Suying DuanDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Jieshi ZhongDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Hang ZhangDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Chenyang LiuDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yaochong ZhangDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Wenzhuo ZhaoDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yaxuan SongDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Tuo WangDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Si YanDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yapeng LiDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Han LiuDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yuan GaoDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0000-0003-2596-4773
Zongping XiaDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Yuming XuDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0000-0003-2689-9897

Funding

China Postdoctoral Science Foundation 2022M722875China Postdoctoral Science Foundation 2023T160600key scientific and technological breakthrough project in Henan province 232102311229National Natural Science Foundation of China 32470159National Natural Science Foundation of China 82301619National Natural Science Foundation of China 82571514
6 · The paper itself

Abstract

Cerebral amyloid angiopathy (CAA) is a major cause of vascular cognitive impairment and lobar intracerebral hemorrhage, yet the mechanisms by which vascular amyloid-beta (Aβ) disrupts cerebrovascular integrity remain poorly defined. Here, we combined spatiotemporal single-cell and single-nucleus transcriptomics in APP23 mice with mechanistic studies in human brain endothelial cells and validation in human CAA-related hemorrhagic tissues to define the endothelial stress pathways driving disease progression. Endothelial cells emerged as an early and highly vulnerable vascular population during CAA development, characterized by persistent activation of endoplasmic reticulum (ER) stress programs with preferential engagement of the IRE1α branch. In vitro, Aβ40 preformed fibrils directly induced ER remodeling, aberrant solid-like phase transition of GRP78, sustained IRE1α-TRAF2-JNK signaling, endothelial apoptosis, and tight junction loss. In vivo, pharmacological inhibition of IRE1α with 4µ8C restored junctional integrity, reduced blood-brain barrier leakage, attenuated vascular amyloid pathology, and improved behavioral performance. Human CAA-related intracerebral hemorrhage specimens recapitulated endothelial ER stress, apoptotic activation, and tight junction depletion. These findings identify persistent endothelial IRE1α signaling as a key driver of cerebrovascular failure in CAA, highlighting its potential as a therapeutic target for vascular amyloidosis.

Indexed as

Aβ40 PFFsblood–brain barriercerebral amyloid angiopathyendoplasmic reticulum stressliquid–solid phase transition

Identifiers

PMID42496063
PMCPMC13398133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.